We took a chat with the BioInnovation Institute about our mission and vision, key drivers for Commit Biologics and the transition from an academic mindset to a more commercial mindset.
Read more at BioInnovation Institue
More news
October 15 – 2024
Highly experienced leader with demonstrated track record of antibody-based drug discovery and pipeline advancement. Strengthens Commit’s leadership team after emerging from stealth with €16m seed financing. Dr Pedersen will spearhead research and development of …
June 10 – 2024
Commit Biologics is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Poster to be presented on Commit’s Bispecific Complement Engaging (BiCE™) platform Aarhus, …
May 9 – 2024
Financing led by Bioqube Ventures and Novo Holdings Commit is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Its unique bispecific technology (BiCE™) …
For inquiries please contact us
at info@commitbio.com
Commit Biologics ApS
Universitetsbyen 83
8000 Aarhus C, Denmark
© 2022 Commit Biologics. All rights reserved.
